These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26941417)

  • 1. Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey.
    Valero-Elizondo J; Salami JA; Ogunmoroti O; Osondu CU; Aneni EC; Malik R; Spatz ES; Rana JS; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):143-53. PubMed ID: 26941417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS).
    Feldman DI; Valero-Elizondo J; Salami JA; Rana JS; Ogunmoroti O; Osondu CU; Spatz ES; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K
    Atherosclerosis; 2017 Mar; 258():79-83. PubMed ID: 28214425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012-2013 Medical Expenditure Panel Survey.
    Singh J; Valero-Elizondo J; Salami JA; Warraich HJ; Ogunmoroti O; Spatz ES; Desai N; Rana JS; Virani SS; Blankstein R; Blaha MJ; Nasir K
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Impact of Moderate-Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey.
    Valero-Elizondo J; Salami JA; Osondu CU; Ogunmoroti O; Arrieta A; Spatz ES; Younus A; Rana JS; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27604455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013.
    Okunrintemi V; Spatz ES; Di Capua P; Salami JA; Valero-Elizondo J; Warraich H; Virani SS; Blaha MJ; Blankstein R; Butt AA; Borden WB; Dharmarajan K; Ting H; Krumholz HM; Nasir K
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cardiovascular risk profile with healthcare expenditure and resource utilization in chronic obstructive pulmonary disease, with and without atherosclerotic cardiovascular disease.
    Jafar Z; Valero-Elizondo J; Saeed GJ; Acquah I; Yahya T; Mahajan S; Mszar R; Khan SU; Caínzos-Achirica M; Nasir K
    Am J Prev Cardiol; 2020 Sep; 3():100084. PubMed ID: 34327464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cardiovascular risk profile with premature all-cause and cardiovascular mortality in US adults: findings from a national study.
    Nguyen RT; Jain V; Acquah I; Khan SU; Parekh T; Taha M; Virani SS; Blaha MJ; Nasir K; Javed Z
    BMC Cardiovasc Disord; 2024 Feb; 24(1):91. PubMed ID: 38321396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity, cardiovascular disease, and medical expenditures in U.S. adults.
    Wang G; Pratt M; Macera CA; Zheng ZJ; Heath G
    Ann Behav Med; 2004 Oct; 28(2):88-94. PubMed ID: 15454355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Ideal Cardiovascular Health and Long-term Healthcare Costs.
    Willis BL; DeFina LF; Bachmann JM; Franzini L; Shay CM; Gao A; Leonard D; Berry JD
    Am J Prev Med; 2015 Nov; 49(5):678-685. PubMed ID: 26141912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare Expenditure and Productivity Cost Savings from Reductions in Cardiovascular Disease and Type 2 Diabetes Associated with Increased Intake of Cereal Fibre among Australian Adults: A Cost of Illness Analysis.
    Fayet-Moore F; George A; Cassettari T; Yulin L; Tuck K; Pezzullo L
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29301298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing Obesity in the USA: Impact on Health Service Utilization and Costs.
    Cecchini M; Sassi F
    Pharmacoeconomics; 2015 Jul; 33(7):765-76. PubMed ID: 26054326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidemia and Medical Expenditures by Cardiovascular Disease Status in US Adults.
    Zhang D; Wang G; Fang J; Mercado C
    Med Care; 2017 Jan; 55(1):4-11. PubMed ID: 27787352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs: Forty-Year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry).
    Allen NB; Zhao L; Liu L; Daviglus M; Liu K; Fries J; Shih YT; Garside D; Vu TH; Stamler J; Lloyd-Jones DM
    Circulation; 2017 May; 135(18):1693-1701. PubMed ID: 28461414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey.
    Salami JA; Valero-Elizondo J; Ogunmoroti O; Spatz ES; Rana JS; Virani SS; Blankstein R; Younus A; Arrieta A; Blaha MJ; Veledar E; Nasir K
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28600400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs.
    Daviglus ML; Liu K; Greenland P; Dyer AR; Garside DB; Manheim L; Lowe LP; Rodin M; Lubitz J; Stamler J
    N Engl J Med; 1998 Oct; 339(16):1122-9. PubMed ID: 9770560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
    Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013.
    Valero-Elizondo J; Hong JC; Spatz ES; Salami JA; Desai NR; Rana JS; Khera R; Virani SS; Blankstein R; Blaha MJ; Nasir K
    Atherosclerosis; 2018 Feb; 269():301-305. PubMed ID: 29254694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and Costs Associated With Suboptimal Physical Activity Among US Women With Cardiovascular Disease.
    Okunrintemi V; Benson EA; Tibuakuu M; Zhao D; Ogunmoroti O; Valero-Elizondo J; Gulati M; Nasir K; Michos ED
    JAMA Netw Open; 2019 Apr; 2(4):e191977. PubMed ID: 30977851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.